Clinical Trials
37 trialsMammo'C
University Hospital, Montpellier
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
LIVERAL
ANRS, Emerging Infectious Diseases
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
OUTREACH2
Mina Alpha Limited
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
CLOVER
University of California, Davis
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
Ain Shams University
RCT
Alexandria University
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Direct Acting Antiviral-Post Authorization Safety Study
Target PharmaSolutions, Inc.
Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening
University of La Laguna
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
University of Texas Southwestern Medical Center
HEPCASUS
Karolinska Institutet
Association of Hepatitis C Virus With Breast Cancer
Mansoura University
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Cairo University
The Second Multicenter Hemophilia Cohort Study
National Institutes of Health Clinical Center (CC)
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
A2ALL-2
Arbor Research Collaborative for Health
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
A2ALL-1
Arbor Research Collaborative for Health
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
National Institutes of Health Clinical Center (CC)
RECAR
Hospices Civils de Lyon
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan